You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EBV nucleic antigen (EBNA)

Showing 1 - 25 of 3,255
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Occurrence of Antibodies Cross-reacting With Autoantigens in

Recruiting
  • Epstein-Barr Virus (EBV) Infection
  • Data collection: Participant characteristics (Illness course, complications of primary EBV infection and provided treatments)
  • +2 more
  • Basel, Switzerland
    University Hospital Basel, Division of Internal Medicine
Nov 8, 2021

Epstein Barr Virus Infection in Radiologically Isolated Syndrome

Recruiting
  • Multiple Sclerosis
  • +2 more
  • NO INTERVENTION
  • Nice, France
    Nice University Hospital
Apr 3, 2023

Malignant Tumors Trial in Chengdu (EBV mRNA vaccine)

Recruiting
  • Malignant Tumors
  • EBV mRNA vaccine
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jan 27, 2023

Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • PK Blood Collection
  • +2 more
  • (no location specified)
Nov 1, 2022

Nasopharyngeal Carcinoma Screening Based on Tongue Imaging

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Tongue image
  • Zhuhai, China
    The Fifth Affiliated Hospital of Sun Yat sen University
Nov 10, 2023

EBV-positive Nasopharyngeal Carcinoma Trial in Guangzhou (Cohort A: 3.0x10^6 CAR-T cells/kg, Cohort B: 9.0x10^6CAR-T cells/kg,

Not yet recruiting
  • EBV-positive Nasopharyngeal Carcinoma
  • Cohort A: 3.0x10^6 CAR-T cells/kg
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 16, 2023

Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus Trial in Houston (MABEL CTLs, Cyclophosphamide,

Recruiting
  • Hodgkin Disease
  • +5 more
  • MABEL CTLs
  • +2 more
  • Houston, Texas
  • +1 more
Jan 13, 2023

EBV-associated Hemophagocytic Lymphohistiocytosis, EBV Infection Trial in Beijing (EBV-TCR-T cells)

Recruiting
  • EBV-associated Hemophagocytic Lymphohistiocytosis
  • EBV Infection
  • EBV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Nov 12, 2023

COVID-19 Trial in Miami (CareSuperb COVID-19 Antigen Home Test Kit)

Recruiting
  • COVID-19
  • CareSuperb COVID-19 Antigen Home Test Kit
  • Miami, Florida
    L&A Morales Healthcare, Inc.
Mar 14, 2023

Neurodegeneration in Multiple Sclerosis -Preclinical Study

Not yet recruiting
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • +2 more
  • Peripheral blood withdrawal
  • Pozzilli, Isernia, Italy
  • +2 more
Feb 15, 2022

Tumor Patients With COVID19 Infection

Recruiting
  • Tumor
  • COVID-19
    • Shenzhen, Guangdong, China
      Seventh Affiliated Hospital, Sun Yat-sen University
    Aug 22, 2023

    CMV Infection, EBV Infection, Stem Cell Transplant Trial (Virus specific T cells)

    Not yet recruiting
    • CMV Infection
    • +2 more
    • Virus specific T cells
    • (no location specified)
    Oct 4, 2023

    Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

    Recruiting
    • Nasopharyngeal Carcinoma
    • EBV antibodies test
    • EBV DNA test
    • Guangzhou, Guangdong, China
      Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
    Jul 6, 2022

    EBV Infection After Allogenic HSCT Trial in Beijing (EBV-TCR-T cells)

    Recruiting
    • EBV Infection After Allogenic HSCT
    • EBV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Nov 3, 2023

    Reveals Relationship Between gp42-IgG Epitopes and

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Epitope exploration
    • (no location specified)
    Jul 16, 2023

    Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • KSD-101
    • Wuhan, China
      Tongji Hospital, Tongji Medical College, Huazhong University of
    Oct 19, 2023

    EBV Lymphoma, Post-transplant Lymphoproliferative Disease (PTLD) Trial in Switzerland (Donor-derived ex-vivo expanded EBV Tscm

    Not yet recruiting
    • EBV Lymphoma
    • Post-transplant Lymphoproliferative Disease (PTLD)
    • Donor-derived ex-vivo expanded EBV Tscm CTL
    • Basel, Switzerland
    • +7 more
    Jan 25, 2023

    Epstein-Barr Virus Infection moniToring in renAl Transplant

    Recruiting
    • EBV Infection
    • +3 more
    • EBV DNA in whole blood and plasma
    • Aarhus, Central Region Denmark, Denmark
    • +2 more
    Dec 12, 2022

    Early Detection of Epstein-Barr Virus Related Disease.

    Active, not recruiting
    • Post-transplant Lymphoproliferative Disorder
    • +8 more
      • Aarhus, Central Region Of Denmark, Denmark
        Aarhus University Hospital
      Dec 12, 2022

      Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)

      Recruiting
      • Serplulimab,Gastric Cancer, Adjuvant Therapy
      • Shanghai, China
        Zhang Zizhen
      Mar 3, 2023

      Nasopharyngeal Carcinoma Trial in Singapore (CCRT with Maintenance Tislelizumab and Metronomic Capecitabine)

      Not yet recruiting
      • Nasopharyngeal Carcinoma
      • CCRT with Maintenance Tislelizumab and Metronomic Capecitabine
      • Singapore, Singapore
      • +1 more
      Oct 16, 2023

      Multiple Sclerosis Trial in Boston (Truvada (tenofovir/emtricitabine))

      Enrolling by invitation
      • Multiple Sclerosis
      • Truvada (tenofovir/emtricitabine)
      • Boston, Massachusetts
        Massachusetts General Hospital
      Jul 14, 2023

      Analysing Peripheral Skeletal Muscle Function Before and After

      Not yet recruiting
      • Emphysema
      • 31P-Magnetic Resonance Spectroscopy (31P-MRS)
      • (no location specified)
      Sep 6, 2023

      Study of Azvudine in the Treatment of COVID-19 Pneumonia

      Not yet recruiting
      • COVID-19 Respiratory Infection
      • (no location specified)
      Nov 18, 2022

      Epstein-Barr Virus Infection, Infectious Mononucleosis, Herpesvirus Trial run by the National Institute of Allergy and

      Not yet recruiting
      • Epstein-Barr Virus Infection
      • +2 more
      • Matrix-M1 Adjuvant
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023